These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3034362)

  • 1. Immunohistochemical studies on small cell lung cancer.
    Shaw JB; Ito M
    Bull Chest Dis Res Inst Kyoto Univ; 1986 Mar; 19(1-2):23-30. PubMed ID: 3034362
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of electron microscopy and immunohistochemistry in the diagnosis and understanding of lung neoplasms.
    Hammar S
    Clin Lab Med; 1987 Mar; 7(1):1-30. PubMed ID: 3030610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large cell carcinoma of the lung. Ultrastructural and immunohistochemical features.
    Delmonte VC; Alberti O; Saldiva PH
    Chest; 1986 Oct; 90(4):524-7. PubMed ID: 2428562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
    Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
    Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of combined detection of tumor markers for the prediction of small cell and non-small cell lung cancer].
    Wu Y; Wu Y; Wang L; Qu L
    Wei Sheng Yan Jiu; 2000 Jul; 29(4):213-5. PubMed ID: 12520921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of several tumor markers in the chest surgery].
    Miyazato I; Tojo N
    Rinsho Kyobu Geka; 1988 Jun; 8(3):231-6. PubMed ID: 9301836
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tumor marker in lung cancer].
    Shijubo N; Abe S
    Kokyu To Junkan; 1993 Jun; 41(6):551-5. PubMed ID: 7687790
    [No Abstract]   [Full Text] [Related]  

  • 8. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
    Graziano SL; Tatum AH; Newman NB; Oler A; Kohman LJ; Veit LJ; Gamble GP; Coleman MJ; Barmada S; O'Lear S
    Cancer Res; 1994 Jun; 54(11):2908-13. PubMed ID: 8187076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In suspected bronchial cancer are the tumor markers neuron-specific enolase, carcinoembryonic antigen and squamous cell carcinoma antigen, of diagnostic help?].
    Jany B; Fischbach W; Chowanetz W
    Med Klin (Munich); 1988 Feb; 83(4):121-4, 158. PubMed ID: 3367874
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoperoxidase staining for carcinoembryonic antigen in small cell carcinoma of the lung.
    Sehested M; Hirsch FR; Hou-Jensen K
    Eur J Cancer Clin Oncol; 1981 Oct; 17(10):1125-31. PubMed ID: 6279407
    [No Abstract]   [Full Text] [Related]  

  • 11. [The practical significance of morphometrical and immunohistochemical studies in distinguishing subtypes of small cell carcinoma of the lung].
    Xu YD
    Zhonghua Bing Li Xue Za Zhi; 1988 Sep; 17(3):164-6. PubMed ID: 2465837
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of usefulness of tumor markers in the management of lung cancer].
    Ariyoshi Y
    Rinsho Byori; 1989 Feb; 37(2):113-7. PubMed ID: 2733177
    [No Abstract]   [Full Text] [Related]  

  • 13. Small cell (oat cell) carcinoma of the trachea with endocrine features. Report of a case and results of ultrastructural and immunohistochemical study.
    Rashid RK; Mackay B; Silva EG; Ordóñez NG
    Arch Pathol Lab Med; 1984 Feb; 108(2):149-51. PubMed ID: 6320759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small cell mesothelioma.
    Cook HC
    Histopathology; 1993 Mar; 22(3):294-5. PubMed ID: 8388362
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma.
    Kohno N; Hirasawa Y; Kondo K; Fujioka S; Fujino S; Abe M; Yokoyama A; Hiwada K; Watanabe K; Nishimura J
    Cancer Detect Prev; 1997; 21(2):124-8. PubMed ID: 9101072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer.
    Nikliński J; Chyczewska E; Furman M; Kowal E; Laudanski J; Chyczewski L
    Neoplasma; 1993; 40(5):305-8. PubMed ID: 8272160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic importance of tumor markers in lung cancer.
    Ulsperger E; Karrer K
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():21-31. PubMed ID: 3074224
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of Cyfra 21-1 as a marker for lung cancer.
    Najemnik C; Mohn-Staudner A; Vetter H; Kokron O; Baumgartner G; Scheiner W; Zwick H; Koderhold G; Alth G; Dudczak R
    Wien Klin Wochenschr; 1996; 108(15):467-72. PubMed ID: 8806188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
    Stieber P; Dienemann H; Schalhorn A; Schmitt UM; Reinmiedl J; Hofmann K; Yamaguchi K
    Anticancer Res; 1999; 19(4A):2673-8. PubMed ID: 10470218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels].
    Kawachi S; Shimabukuro Z; Aoyama A; Yano T; Hasegawa K; Tsuboi E; Niitani H
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2469-74. PubMed ID: 3039919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.